UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 187

Sortiert nach

Pharmacogenetics: From Bench to Byte- An Update of Guidelines

Clinical pharmacology and therapeutics, 2011-05, Vol.89 (5), p.662-673

2011

Volltextzugriff (PDF)

A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC-MS/MS

Talanta (Oxford), 2015-03, Vol.134, p.165-172

2015

Volltextzugriff (PDF)

Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review

Diabetic medicine, 2015-07, Vol.32 (7), p.853-864

2015

Volltextzugriff (PDF)

Pharmacogenetics: From Bench to Byte

Clinical pharmacology and therapeutics, 2008-05, Vol.83 (5), p.781-787

2008

Volltextzugriff (PDF)

Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS

Analytical and bioanalytical chemistry, 2014-04, Vol.406 (9-10), p.2349-2353

2014

Volltextzugriff (PDF)

Gene polymorphism of serotonin receptors and drug-induced hyperprolactinemia in schizophrenic patients

European neuropsychopharmacology, 2016-10, Vol.26, p.S515-S516

2016

Volltextzugriff (PDF)

CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias

European neuropsychopharmacology, 2016-10, Vol.26, p.S656-S657

2016

Volltextzugriff (PDF)

Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

The pharmacogenomics journal, 2012-02, Vol.12 (1), p.62-67

2012

Volltextzugriff (PDF)

P.5.d.005 Polymorphisms of DRD2, DRD3, DRD4 and HTR2C genes in levodopa-induced dyskinesias in Parkinson's disease

European neuropsychopharmacology, 2015-09, Vol.25, p.S589-S589

2015

Volltextzugriff (PDF)

Pharmacokinetics of clomipramine during pregnancy

European journal of clinical pharmacology, 2015-12, Vol.71 (12), p.1493-1500

2015

Volltextzugriff (PDF)

4-Aminopyridine as a life-saving treatment in calcium channel antagonist intoxication

Netherlands journal of medicine, 2016-07, Vol.74 (6), p.276-276

2016

Volltextzugriff (PDF)

NMDA receptor genotypes associated with the vulnerability to develop dyskinesia

Translational psychiatry, 2012-01, Vol.2 (1), p.e67-e67

2012

Volltextzugriff (PDF)

Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia

Progress in neuro-psychopharmacology & biological psychiatry, 2009-04, Vol.33 (3), p.475-481

2009

Volltextzugriff (PDF)

P.3.a.006 Tardive dyskinesia, dehydroepiandrosterone sulfate and cytochrome P450c17α gene polymorphism in psychiatric inpatients

European neuropsychopharmacology, 2014-10, Vol.24, p.S486-S487

2014

Volltextzugriff (PDF)

Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia

Human psychopharmacology, 2010-01, Vol.25 (1), p.84-91

2010

Volltextzugriff (PDF)

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children

European journal of clinical pharmacology, 2013-03, Vol.69 (3), p.541-547

2013

Volltextzugriff (PDF)

P.583 Polymorphisms in BDNF, AKT1, GSK3B genes: possible association with antipsychotic-induced hyperprolactinemia in schizophrenia patients

European neuropsychopharmacology, 2020-11, Vol.40, p.S331-S332

2020

Volltextzugriff (PDF)

P.0579 Pharmacogenetic study to elucidate putative dopaminergic mechanisms of antidepressant action

European neuropsychopharmacology, 2021-12, Vol.53, p.S424-S425

2021

Volltextzugriff (PDF)

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers : indications for oral contraceptive-related gender differences

European journal of clinical pharmacology, 1999-05, Vol.55 (3), p.177-184

1999

Volltextzugriff (PDF)

Aconitum sp. alkaloids: the modulation of voltage-dependent Na + channels, toxicity and antinociceptive properties

European journal of pharmacology, 1997-10, Vol.337 (2), p.165-174

1997

Volltextzugriff (PDF)

P.3.001 NMDA receptor co-determines vulnerability to develop dyskinesia in Huntington's Disease and levodopa-induced dyskinesia but not tardive dyskinesia

European neuropsychopharmacology, 2011, Vol.21, p.S142-S142

2011

Volltextzugriff (PDF)

P.3.c.001 Association between HTR2C polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

European neuropsychopharmacology, 2010, Vol.20, p.S458-S458

2010

Volltextzugriff (PDF)

P.3.c.002 Association between the alpha-2a-adrenergic receptor 1291 C/G polymorphism and the metabolic syndrome

European neuropsychopharmacology, 2010, Vol.20, p.S458-S459

2010

Volltextzugriff (PDF)

Tardive dyskinesia in schizophrenia: Gene polymorphisms of muscarinic and adrenergic receptors

European neuropsychopharmacology, 2019, Vol.29, p.S117-S118

2019

Volltextzugriff (PDF)

The study of dopamine receptor genes in patients with schizophrenia

European neuropsychopharmacology, 2019, Vol.29, p.S410-S411

2019

Volltextzugriff (PDF)

1 – 25 von 187

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(70)
Animals
(66)
Male
(65)
Rats
(54)
Biological And Medical Sciences
(53)
Pharmacology & Pharmacy
(51)
Medical Sciences
(44)
Pharmacology. Drug Treatments
(42)
Rats, Inbred Strains
(32)
Blood Pressure - Drug Effects
(31)
Humans
(29)
Female
(24)
In Vitro Techniques
(22)
Cardiovascular System
(20)
Vasoconstriction - Drug Effects
(19)
Adrenergic Alpha-Agonists - Pharmacology
(17)
Dose-Response Relationship, Drug
(15)
Nifedipine - Pharmacology
(15)
Receptors, Adrenergic, Alpha - Drug Effects
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacogenetics: From Bench to Byte- An Update of Guidelines

A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC-MS/MS

Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review

Pharmacogenetics: From Bench to Byte

Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS

Gene polymorphism of serotonin receptors and drug-induced hyperprolactinemia in schizophrenic patients

CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias

Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

P.5.d.005 Polymorphisms of DRD2, DRD3, DRD4 and HTR2C genes in levodopa-induced dyskinesias in Parkinson's disease

Pharmacokinetics of clomipramine during pregnancy

4-Aminopyridine as a life-saving treatment in calcium channel antagonist intoxication

NMDA receptor genotypes associated with the vulnerability to develop dyskinesia

Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia

P.3.a.006 Tardive dyskinesia, dehydroepiandrosterone sulfate and cytochrome P450c17α gene polymorphism in psychiatric inpatients

Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children

P.583 Polymorphisms in BDNF, AKT1, GSK3B genes: possible association with antipsychotic-induced hyperprolactinemia in schizophrenia patients

P.0579 Pharmacogenetic study to elucidate putative dopaminergic mechanisms of antidepressant action

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers : indications for oral contraceptive-related gender differences

Aconitum sp. alkaloids: the modulation of voltage-dependent Na + channels, toxicity and antinociceptive properties

P.3.001 NMDA receptor co-determines vulnerability to develop dyskinesia in Huntington's Disease and levodopa-induced dyskinesia but not tardive dyskinesia

P.3.c.001 Association between HTR2C polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

P.3.c.002 Association between the alpha-2a-adrenergic receptor 1291 C/G polymorphism and the metabolic syndrome

Tardive dyskinesia in schizophrenia: Gene polymorphisms of muscarinic and adrenergic receptors

The study of dopamine receptor genes in patients with schizophrenia

Aktive Filter

Suchergebnisse filtern